Multiple news reports say a new study finds that a ketogenic (keto) diet—low in carbohydrates and high in fat—may improve the likelihood of diabetes remission for some people compared with a Mediterranean-style diet after about five months.
The articles report that participants following the keto approach show better metabolic outcomes and that the change is associated with lower risk markers for related health problems, including heart disease, fatty liver, and stroke. However, the reports do not provide full methodological details in the excerpts, such as participant eligibility, baseline diabetes stage, medication use, study size, or how “remission” and long-term outcomes are defined and measured.
Across the outlets, the shared focus is the comparative claim that keto performs better than Mediterranean eating patterns over a similar follow-up period, alongside assertions about broader health benefits. Differences in emphasis are limited to the framing of the findings, while both reports align on the central result: a short, structured dietary intervention may improve diabetes outcomes for some individuals.
